AVITA Medical (RCEL) Return on Equity (2019 - 2025)

AVITA Medical (RCEL) has 7 years of Return on Equity data on file, last reported at 0.04% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity rose 12.0% year-over-year to 0.04%; the trailing twelve-month figure through Dec 2025 stood at 0.04% (up 12.0% YoY), and the FY2025 full-year result was 0.08%, up 10.0% from the prior year.
• Return on Equity for Q4 2025 stood at 0.04%, down from 0.05% in the prior quarter.
• Across five years, Return on Equity topped out at 15.84% in Q1 2025 and bottomed at 0.07% in Q4 2024.
• The 5-year median for Return on Equity is 0.0% (2021), against an average of 0.79%.
• The widest annual swing landed in 2024, when Return on Equity fell 8 bps; it then jumped 1584 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then tumbled by 54 bps to 0.0% in 2022, then soared by 170 bps to 0.0% in 2023, then slumped by 4549 bps to 0.07% in 2024, then jumped by 156 bps to 0.04% in 2025.
• The last three Return on Equity figures came in at 0.04% (Q4 2025), 0.05% (Q3 2025), and 0.06% (Q2 2025), per Business Quant data.

Peer Comparison